Lethal graft-vs-host disease across major histocompatibility barriers: Requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells

Medicine & Life Sciences

• leucyl-leucine-methyl ester 100%
• Histocompatibility 64%
• Graft vs Host Disease 54%
• T-Lymphocytes 31%
• Cytotoxic T-Lymphocytes 18%
• Spleen 17%
• Helper-Inducer T-Lymphocytes 11%
• Interleukin-2 10%
• Isoantigens 7%
• T-Lymphocyte Subsets 6%
• Bone Marrow Transplantation 5%
• Major Histocompatibility Complex 5%
• Thymus Gland 5%
• Bone Marrow Cells 5%
• Natural Killer Cells 5%
• Lipopolysaccharides 4%
• Poisons 4%
• Therapeutics 3%
• In Vitro Techniques 2%